Hobart Private Capital, LLC Pfizer Inc Transaction History

Hobart Private Capital, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Mar 11, 2024	SELL	$39.25 - $50.42 $269,922 - $346,738	-6,877 Closed	0 $0
Q2 2021 Mar 11, 2024	SELL	$35.91 - $40.68 $24,993 - $28,313	-696 Reduced 9.19%	6,877 $269 Million
Q1 2021 Mar 11, 2024	BUY	$33.49 - $37.77 $253,619 - $286,032	7,573 New	7,573 $274 Million
Q4 2020 Mar 11, 2024	SELL	$33.47 - $42.56 $160,354 - $203,904	-4,791 Reduced 28.34%	12,117 $446 Million
Q3 2020 Mar 11, 2024	SELL	$31.75 - $37.25 $483,076 - $566,758	-15,215 Reduced 47.36%	16,908 $621 Million
Q2 2020 Mar 11, 2024	SELL	$30.12 - $36.54 $408,156 - $495,153	-13,551 Reduced 29.67%	32,123 $1.05 Billion
Q1 2020 Mar 11, 2024	SELL	$27.03 - $38.62 $174,073 - $248,712	-6,440 Reduced 12.36%	45,674 $1.49 Billion
Q4 2019 Mar 11, 2024	BUY	$32.92 - $37.36 $1.72 Million - $1.95 Million	52,114 New	52,114 $2.04 Billion
Q3 2019 Mar 11, 2024	BUY	$32.49 - $42.13 $541,705 - $702,433	16,673 Added 153.06%	27,566 $990 Million
Q2 2019 Mar 11, 2024	BUY	$36.98 - $41.52 $168,259 - $188,916	4,550 Added 71.73%	10,893 $472 Million
Q1 2019 Mar 11, 2024	SELL	$37.5 - $41.2 $42,787 - $47,009	-1,141 Reduced 15.25%	6,343 $269 Million
Q4 2018 Mar 11, 2024	SELL	$38.47 - $43.86 $510,612 - $582,153	-13,273 Reduced 63.94%	7,484 $327 Million
Q3 2018 Mar 11, 2024	SELL	$34.47 - $41.81 $45,293 - $54,938	-1,314 Reduced 5.95%	20,757 $915 Million
Q2 2018 Mar 11, 2024	BUY	$32.98 - $35.16 $357,305 - $380,923	10,834 Added 96.41%	22,071 $801 Million
Q1 2018 Mar 11, 2024	BUY	$31.91 - $37.02 $358,572 - $415,993	11,237 New	11,237 $399 Million

3,223

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $159B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.